Acute coronary syndrome in COVID-19 patients
Open Access
- 8 June 2021
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (5), 2806
- https://doi.org/10.15829/1728-8800-2021-2806
Abstract
Acute coronary syndrome (ACS) is caused by an acute mismatch between myocardial oxygen demand and its supply. This mechanism is largely associated with the progression of coronary atherosclerosis in combination with an inflammatory response, hypoxemia, and blood procoagulation. Patients with the coronavirus disease 2019 (COVID-19), aggravated by cardiovascular diseases and comorbidities, are at high risk of ACS.Aim. To analyze the publications, which reflects the development of ACS in patients with COVID-19, its pathogenesis, and clinical course. Material and methods. Literature data were searched using Google Scholar, PubMed, ScienceDirect, and Cyberleninka services. The analysis included data from clinical guidelines on COVID-19, data from clinical studies, reports, and systematic reviews.Results. This literature review summarizes and systematizes the data presented in modern publications, highlights the aspects of the clinical course and pathogenetic mechanisms underlying ACS in patients with COVID-19.Conclusion. The pathogenesis of COVID-19 is inextricably associated with the widespread cytopathic effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), uncontrolled immune response that causes systemic inflammation, as well as the coagulation system activation. In patients with COVID-19, along with the atherosclerosis, these mechanisms significantly increase the risk of ACS and can worsen its in-hospital course.Keywords
This publication has 49 references indexed in Scilit:
- The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarctionCardiovascular Diabetology, 2017
- Relationship Between C-Reactive Protein Serum Concentration and the 1846 C>T (rs1205) Polymorphism in Patients with Acute Coronary Syndrome from Western MexicoGenetic Testing and Molecular Biomarkers, 2017
- Circulating ACE2 activity correlates with cardiovascular disease developmentJournal of the Renin-Angiotensin-Aldosterone System, 2016
- The varying faces of IL-6: From cardiac protection to cardiac failureCytokine, 2015
- DPP-4 inhibitors repress foam cell formation by inhibiting scavenger receptors through protein kinase C pathwayActa Diabetologica, 2013
- IL-6 and its receptors in coronary artery disease and acute myocardial infarctionCytokine, 2013
- Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosisNeuropeptides, 2012
- Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarctionAtherosclerosis, 2009
- The Nucleocapsid Protein of SARS-CoV Induces Transcription of hfgl2 Prothrombinase Gene Dependent on C/EBP AlphaThe Journal of Biochemistry, 2008
- Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyThe Lancet, 2003